Quantum-Si Inc
QSI1.440USD
-0.020-1.37%
Handelsschluss 08/04, 16:00（ET）Kurse um 15 Minuten verzögert
264.24MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Quantum-Si Inc Unternehmen
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Unternehmensinformationen
BörsenkürzelQSI
Name des UnternehmensQuantum-Si Inc
IPO-datumSep 04, 2020
CEOMr. Jeffrey Alan (Jeff) Hawkins
Anzahl der mitarbeiter143
WertpapierartOrdinary Share
GeschäftsjahresendeSep 04
Addresse29 Business Park Drive
StadtBRANFORD
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl06405
Telefon12034587100
Websitehttps://www.quantum-si.com/
BörsenkürzelQSI
IPO-datumSep 04, 2020
CEOMr. Jeffrey Alan (Jeff) Hawkins
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Independent Director
Independent Director
2.92M
+0.23%
Mr. Jeffrey Alan (Jeff) Hawkins
Mr. Jeffrey Alan (Jeff) Hawkins
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.91M
-1.23%
Mr. Jeffry R. (Jeff) Keyes
Mr. Jeffry R. (Jeff) Keyes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
919.45K
-0.93%
Dr. Christian LaPointe, Ph.D.
Dr. Christian LaPointe, Ph.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
854.42K
-1.38%
Mr. Todd C. Bennett
Mr. Todd C. Bennett
Chief Commercial Officer
Chief Commercial Officer
718.49K
+40.84%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
355.00K
--
Ms. Ruth A. Fattori
Ms. Ruth A. Fattori
Independent Director
Independent Director
170.51K
+4.18%
Ms. Paula Dowdy
Ms. Paula Dowdy
Independent Director
Independent Director
53.07K
-66.67%
Mr. Scott Mendel
Mr. Scott Mendel
Independent Director
Independent Director
47.28K
+33.33%
Mr. Amir Jafri
Mr. Amir Jafri
Independent Director
Independent Director
38.65K
-66.67%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Independent Director
Independent Director
2.92M
+0.23%
Mr. Jeffrey Alan (Jeff) Hawkins
Mr. Jeffrey Alan (Jeff) Hawkins
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.91M
-1.23%
Mr. Jeffry R. (Jeff) Keyes
Mr. Jeffry R. (Jeff) Keyes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
919.45K
-0.93%
Dr. Christian LaPointe, Ph.D.
Dr. Christian LaPointe, Ph.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
854.42K
-1.38%
Mr. Todd C. Bennett
Mr. Todd C. Bennett
Chief Commercial Officer
Chief Commercial Officer
718.49K
+40.84%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
355.00K
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, Jun 13
Aktualisiert: Fri, Jun 13
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Rothberg (Jonathan M)
7.56%
BlackRock Institutional Trust Company, N.A.
4.86%
The Vanguard Group, Inc.
4.77%
ARK Investment Management LLC
4.38%
Nikko Asset Management Co., Ltd.
3.09%
Other
75.34%
Aktionäre
Aktionäre
Anteil
Rothberg (Jonathan M)
7.56%
BlackRock Institutional Trust Company, N.A.
4.86%
The Vanguard Group, Inc.
4.77%
ARK Investment Management LLC
4.38%
Nikko Asset Management Co., Ltd.
3.09%
Other
75.34%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
16.53%
Individual Investor
12.61%
Investment Advisor/Hedge Fund
8.36%
Hedge Fund
3.53%
Research Firm
0.64%
Holding Company
0.41%
Venture Capital
0.20%
Family Office
0.12%
Bank and Trust
0.10%
Other
57.49%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
267
77.14M
42.46%
-882.28K
2025Q1
278
76.41M
46.71%
+317.44K
2024Q4
271
68.59M
42.10%
-6.57M
2024Q3
252
70.04M
55.68%
-7.45M
2024Q2
247
70.14M
56.56%
-4.69M
2024Q1
255
69.57M
56.30%
-9.44M
2023Q4
250
68.72M
56.32%
-9.91M
2023Q3
261
68.63M
56.31%
-5.37M
2023Q2
261
63.23M
52.14%
-15.03M
2023Q1
275
75.54M
63.26%
-9.35M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Rothberg (Jonathan M)
13.73M
8.4%
--
--
Mar 03, 2025
BlackRock Institutional Trust Company, N.A.
8.83M
5.4%
+934.37K
+11.83%
Mar 31, 2025
The Vanguard Group, Inc.
6.89M
4.21%
+1.40M
+25.51%
Mar 31, 2025
ARK Investment Management LLC
7.81M
4.77%
-904.16K
-10.38%
May 31, 2025
Nikko Asset Management Co., Ltd.
5.81M
3.55%
-153.78K
-2.58%
Mar 31, 2025
Millennium Management LLC
3.93M
2.41%
+3.93M
--
Mar 31, 2025
Geode Capital Management, L.L.C.
2.99M
1.83%
+626.51K
+26.45%
Mar 31, 2025
Rakin (Kevin L)
2.92M
1.78%
+6.84K
+0.23%
Mar 03, 2025
State Street Global Advisors (US)
2.45M
1.5%
+49.09K
+2.04%
Mar 31, 2025
Hawkins (Jeffrey Alan)
1.91M
1.17%
-23.70K
-1.23%
Jun 23, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
ARK Genomic Revolution ETF
1.5%
Vanguard US Momentum Factor ETF
0.08%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Value ETF
0.02%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
iShares Russell 2000 ETF
0.01%
Mehr Anzeigen
ARK Genomic Revolution ETF
Anteil1.5%
Vanguard US Momentum Factor ETF
Anteil0.08%
iShares Micro-Cap ETF
Anteil0.06%
iShares Russell 2000 Value ETF
Anteil0.02%
ProShares Hedge Replication ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
